ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

CUSIP: H0036K147

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding
124,261,423
Total 13F shares
82,866,357
Share change
+14,892,279
Total reported value
$292,847,531
Put/Call ratio
0%
Price per share
$3.53
Number of holders
114
Value change
+$51,266,770
Number of buys
67
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q4 2025

As of 31 Dec 2025, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,866,357 shares. The largest 10 holders included Redmile Group, LLC, TCG Crossover Management, LLC, Prosight Management, LP, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, BlackRock, Inc., Point72 Asset Management, L.P., MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 114 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.